Literature DB >> 4031502

A rapid and sensitive method allowing photometric determination of erythrophagocytosis by mononuclear phagocytes.

T W Jungi.   

Abstract

A spectrometric assay for assessing erythrophagocytosis by mononuclear phagocytes is described. It is based on the haemoglobin-catalyzed conversion of a benzidine derivative into a coloured product in the presence of H2O2 (pseudoperoxidase activity). The assay is set up in microtitre plates, and following an uptake phase and removal of non-ingested erythrocytes, pseudoperoxidase activity is measured in detergent lysates of phagocytes, using an ELISA reader photometer. Various detergents and substrates were evaluated. SDS was found to be the most suitable detergent. Diaminobenzidine (in PBS, pH 7.4) was the substrate of choice for enumerating ingested erythrocytes in a range from 10(4) to 5-8X10(5) sheep erythrocytes. Ortho-tolidine (in acetate buffer, pH 5.5) could be used in a range from 2X10(3) to 2X10(5) sheep erythrocytes. The results obtained with human peripheral blood monocytes or monocyte-derived macrophages and IgG-sensitized sheep erythrocytes correlated well with those obtained using 51Cr-labelled, IgG-sensitized erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031502     DOI: 10.1016/0022-1759(85)90233-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

1.  Chromatin structure and DNase I hypersensitivity in the transcriptionally active and inactive porcine tumor necrosis factor gene locus.

Authors:  P Kuhnert; E Peterhans; U Pauli
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

2.  Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.

Authors:  R D Bigler; M Khoo; S Lund-Katz; L Scerbo; M Esfahani
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  Quantitative assessment of Fc receptor expression and function during in vitro differentiation of human monocytes to macrophages.

Authors:  T W Jungi; S Hafner
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  The capacity of various types of immunoglobulin for intravenous use to interact with Fc receptors of human monocytes and macrophages.

Authors:  T W Jungi; J Eiholzer; P G Lerch; S Barandun
Journal:  Blut       Date:  1986-10

5.  Modulation of human monocyte Fc receptor function by surface-adsorbed IgG.

Authors:  T W Jungi; G von Below; P G Lerch; P J Spaeth
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

6.  Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.

Authors:  S J Rüegg; T W Jungi
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

7.  Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes.

Authors:  T W Jungi; M Brcic; P Kuhnert; M O Spycher; F Li; U E Nydegger
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

8.  Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma-treated microglia isolated from adult rat brain.

Authors:  M N Woodroofe; G M Hayes; M L Cuzner
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

9.  Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rat microglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: effects on interferon-gamma induced activation.

Authors:  A J Loughlin; M N Woodroofe; M L Cuzner
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

10.  Change in sensitivity to lipopolysaccharide during the differentiation of human monocytes to macrophages in vitro.

Authors:  T W Jungi; R Miserez; M Brcic; H Pfister
Journal:  Experientia       Date:  1994-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.